{"url_path":"/sec/pbh/8-k/2026-07-15/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-15","source_url":"https://www.sec.gov/Archives/edgar/data/1295947/0001104659-26-083872-index.html","accession_number":"0001104659-26-083872","cik":"0001295947","ticker":"PBH","issuer_name":"Prestige Consumer Healthcare Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1295947/0001104659-26-083872-index.html","primary_entity_key":"0001295947","primary_entity_name":"Prestige Consumer Healthcare Inc."},"word_count":316,"has_tables":true,"body_markdown":"false\n0001295947\n\n0001295947\n\n2026-07-15\n2026-07-15\n\niso4217:USD\n\nxbrli:shares\n\niso4217:USD\n\nxbrli:shares\n\n \n\n \n\n** **\n\n**UNITED\nSTATES\nSECURITIES AND EXCHANGE COMMISSION****Washington, D.C. 20549**\n\n \n\n \n\n \n\n**FORM\n8-K**\n\n \n\n**CURRENT\nREPORT**\n\n \n\n**Pursuant\nto Section 13 or 15(d) of the Securities Exchange Act of 1934**\n\n** **\n\nDate of report\n(Date of earliest event reported): July 15, 2026\n\n \n\n**PRESTIGE\nCONSUMER HEALTHCARE INC.**\n\n(Exact Name\nof Registrant as Specified in Charter)\n\n \n\nDelaware\n001-32433\n20-1297589\n\n(State or\nOther Jurisdiction of\n\nIncorporation)\n(Commission\nFile Number)\n(IRS\nEmployer Identification No.)\n\n \n\n660\nWhite Plains Road, Tarrytown, New York 10591\n\n(Address of Principal Executive Offices) (Zip Code)\n\n \n\n(914)\n524-6800\n\n(Registrant's telephone number, including\narea code)\n\n \n\n(Former Name or Former Address, if Changed Since Last Report.)\n\n \n\nCheck the appropriate box below if the Form 8-K\nfiling is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (*see*\nGeneral Instruction A.2. below):\n\n \n\n¨ Written communications pursuant to Rule 425 under the Securities\nAct (17 CFR 230.425)\n\n \n\n¨ Soliciting material pursuant to Rule 14a-12 under the Exchange\nAct (17 CFR 240.14a-12)\n\n \n\n¨\nPre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))\n\n \n\n¨ Pre-commencement communications pursuant\nto Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))\n\n \n\nSecurities registered pursuant to Section 12(b) of the Act:\n\n \n\nTitle\nof each class\nTrading\nSymbol(s)\nName\nof each exchange on which registered\n\n**Common stock, par value $0.01 per share**\n**PBH**\n**New York Stock Exchange**\n\n \n\nIndicate by check mark whether the registrant\nis an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2\nof the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).\n\n \n\nEmerging\nGrowth Company ¨\n\n \n\nIf\nan emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for\ncomplying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨"}